Pregabalin is being studied as an antiseizure medication in the United States. Participants are expected to be between the ages of 18 and 65 years, diagnosed with partial seizures occurring approximately twice per month. Patients will be taking no more than two additional antiepileptic treatments. The study will be conducted at Froedtert Memorial Lutheran Hospital, primary teaching affiliate of the Medical College of Wisconsin. Participants will receive study medication, doctor visits, and laboratory tests free of charge.
Study involves approximately six outpatient visits over a twenty four week period.
The study will be conducted nationwide and will enroll a large number of patients from multiple sites. Top Remacemide Study No. The Medical College of Wisconsin, Department of Neurology, research Dr. George Morris is seeking volunteers for a research study involving a new drug, Remacemide. Remacemide has been studied in the United States and Europe. Participants in this study will have been diagnosed with seizures and be hospitalized for the evaluation of a potential surgical treatment of their seizures.